Faeth Therapeutics FTH
NASDAQ FTH
$32.33 +0.23 (+0.72%)
As of: Aug 21, 2026 · 2:50 PM EDT

Faeth Therapeutics (FTH) Return on Assets (QoQ) (2021 - 2026)

Faeth Therapeutics (FTH) Return on Assets (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.60 Bn 130.75 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.93 Bn 77.93 Bn 3.93 Bn
3 Argenx Se 65.06 Bn 59.88 Bn 1.37 Bn
4 Moderna 56.22 Bn 51.08 Bn 52.00 Mn
5 BeOne Medicines 42.03 Bn 36.93 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.65 Bn 28.34 Bn 992.69 Mn
7 BioNTech SE 27.70 Bn 9.31 Bn 668.28 Mn
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
9 Royalty Pharma 27.31 Bn 26.48 Bn -
10 Faeth Therapeutics 182.45 Mn 182.45 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00
Mar 31, 2026 -1.00
Dec 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00